Medium materiality6/10
CVS Health price target lowered to $112 from $119 at Leerink
Why it may matterVerify against the original reporting
sell
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink Partners lowers CVS's target to $112 from $119; current price is $86.16, suggesting reduced upside.
- Leerink lowers CVS PT to $112 from $119; price $86.16.
Key facts
- 01
Target: $112
- 02
Posted price: $86.16
- 03
Analyst firm: Leerink Partners
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.